Matching slides 303,780
Current window 202,141-202,170
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

202,141-202,170 of 303,780

filter-aware
14
The slide uses a 2x2 matrix to map specific companies like BenevolentAI, Recursion, Exscientia, Schrodinger, and Relay Therapeutics.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
15
The slide uses a linear process flow (1. Data Foundations -> 2. AI Tools) with a circular feedback loop for the AI tools section.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
16
Uses a 2x2 matrix to represent the platform approach.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
17
The slide uses a comparison framework to highlight competitive advantages in drug discovery efficiency.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
18
The chart uses a horizontal bar format to compare IND filing rates against market capitalization for different tiers of pharma companies.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
20
The slide uses a process flow diagram to illustrate the business model, combining a circular platform representation with a linear pipeline and branching commercial strategies.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
21
The slide uses a hub-and-spoke style diagram to connect strategic pillars (Scientific, Commercial, Clinical, Data) to specific therapeutic area execution models.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
22
The slide uses a three-column layout to categorize validation types: Internal Pipeline, Strategic, and Clinical/Regulatory.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
23
The chart uses a timeline-style progression (Hit to Lead through Phase III) to visualize drug development status.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
25
The slide uses a list-based structure to demonstrate the value proposition and validation of the company's AI platform.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
27
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
28
The slide uses a two-stage process flow: 1. Data Foundations (knowledge graph representation) and 2. AI Tools for Scientists (circular workflow).BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
29
The slide illustrates a data integration pipeline from raw sources to a knowledge graph representation.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
30
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
33
The slide uses a process flow diagram to map out the drug discovery pipeline, specifically focusing on the Target ID phase.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
34
The slide uses a vertical process flow on the left and a detailed 4-quadrant layout for the steps.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
35
The slide shows a process flow on the left (Tech Approach, Predict, Triage, TPA, Assay) and two screenshots of a software interface on the right.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
36
The slide shows a 'Triage Tool' interface. On the left is a process flow diagram (Tech Approach -> Predict -> Triage -> TPA -> Assay) with 'Triage' highlighted.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
37
The slide uses a vertical process flow on the left to indicate the current stage (TPA) within a larger drug discovery pipeline.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
38
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
40
Uses a circular diagram to represent the feedback loop between lab work and data integration.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
41
The chart uses a swimlane-style visualization to show progress across drug discovery stages (Target ID to Phase III).BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
42
Includes a clinical photograph of the condition.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
43
Includes a biological mechanism diagram showing NGF, BDNF, and NTF-3 binding to TrkA, TrkB, and TrkC receptors.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
44
The slide uses a complex biological illustration to map specific receptor pathways to cellular mechanisms in AD skin.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
45
Includes data on T-cell activation inhibition, sensory neuron activation, and mouse ear inflammation reduction.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
48
Includes specific caveats regarding small sample size and short duration.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
50
The slide uses a visual treatment flow diagram to contrast current and future treatment options.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
53
The slide demonstrates the inhibitory effect of anti-TNF monoclonal antibodies on cytokine release.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
54
The slide displays protein phosphorylation intensity across various markers for healthy vs. inflamed tissue.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit